BiofabricationBioinksBioprintingCellular AgricultureMedical AM

Humabiologics partners with Fisher Scientific

To distribute human biomaterials for regenerative medicine research

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, founded by scientists and tissue industry experts to address the gap between the gift of donated human tissues and researchers, and Fisher Scientific, a global leader in life sciences, are partnering to serve researchers in academia and industry who are working on regenerative medicine research.

Humabiologics develops and commercializes high-quality and affordable human-derived biomaterials for translational regenerative medicine applications such as cell therapy, bioprinting, tissue and disease modeling, or drug screening. Fisher Scientific, part of Thermo Fisher, is a fortune 100 global leader which has been serving the field of life sciences for more the 50 years.

Humabiologics partners with Fisher Scientific. To distribute human biomaterials for regenerative medicine research.
Humabiologics partners with Fisher Scientific

“We are excited to partner with Fisher Scientific and expand our global network of reputable distributors around the world. Fisher Scientific is a well-known and respected life science company with quality products that are used in labs around the world every day.”

Humabiologics products have been used in several research applications including engineering human tissues, creating human tissue models for drug discovery and testing, modeling cancer environments, bioprinting, and many other applications. Several peer-reviewed publications have demonstrated the successful use of Humabiologics’ products to create clinically relevant human therapies and the possibility to create more relevant human tissue models to reduce or eliminate animal testing in the future.

Last year, Humabiologics introduced the world’s first native human collagen and gelatin bioinks. It also introduced the world’s first native human collagen and gelatin methacrylate for bioprinting applications. Humabiologics products are compatible with several commercially available bioprinters with excellent biocompatibility and printing performance compared to animal options. Humabiologics maintains an ISO 13485 certified quality system to facilitate the translation of innovative therapies from benchtop to clinic, quickly. Humabiologics continues to pave the way for future discoveries by developing organ- and tissue-specific human biomaterials.

Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Edward Wakefield

Edward is a freelance writer and additive manufacturing enthusiast looking to make AM more accessible and understandable.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.